Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Invested Capital (2017 - 2024)

Geron (GERN) posted Invested Capital of $71.6 million for Q3 2024, up 52.53% sequentially from $46.9 million in Q2 2024, and up 224.4% YoY from $22.1 million in Q4 2023.

Geron (GERN) Invested Capital (2017 - 2024) Analysis & Trends

Geron has reported Invested Capital for 4 years, with the latest figure at $71.6 million in Q3 2024.

  • Quarterly Invested Capital rose 224.4% year-over-year to $71.6 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $71.6 million (down 61.81% YoY) and the FY2023 annual result came in at $46.9 million, up 123.89% from the prior year.
  • Invested Capital rose to $71.6 million in Q3 2024 per GERN's latest filing, from $46.9 million in the prior quarter.
  • Over five years, Invested Capital peaked at $71.6 million in Q3 2024 and troughed at $5.2 million in Q2 2022.
  • A 3-year average of $34.3 million and a median of $22.1 million in 2023 frame the typical range for Invested Capital.
  • The sharpest annual moves came in 2023 and 2024: Invested Capital surged 70.23% in 2023, then jumped 332.73% in 2024.
  • Over 3 years, Invested Capital stood at $20.9 million in 2022, then jumped by 123.89% to $46.9 million in 2023, then soared by 52.61% to $71.6 million in 2024.
  • According to Business Quant data, Invested Capital over the past three periods registered $71.6 million, $46.9 million, and $71.5 million for Q3 2024, Q2 2024, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 190.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.45 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 380.00 Mn
10 Geron 1.02 Mn -299.83 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 71.56 Mn
Jun 30, 2024 46.92 Mn
Mar 31, 2024 71.53 Mn
Dec 31, 2023 46.89 Mn
Sep 30, 2023 22.06 Mn
Jun 30, 2023 10.84 Mn
Dec 31, 2022 20.95 Mn
Sep 30, 2022 12.96 Mn
Jun 30, 2022 5.16 Mn
Jun 30, 2017 6.25 Mn
Mar 31, 2017 6.25 Mn